Delivery Order SPE2DB22D9239-SPE2DB24FDG52
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. will provide 200-unit vials of BOTOX with a completion date of January 11, 2024 and a potential value of $32,342.50. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of 100-unit vials of Botox, with a total potential value of $4,614.80 and a completion date of February 20, 2024. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceuticals and medical supplies to U.S....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is valued at $5,537.76 and covers the delivery of 100-unit vials of the pharmaceutical product BOTOX. The delivery order has a completion date of March 22, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding an indefinite delivery contract with the Defense Logistics...
- This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $4,614.80 contract is for the delivery of 100-unit vials of Botox and covers performance through September 11, 2024. DMS Pharmaceutical Group has a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,017.20 contract is for the delivery of 200-unit vials of Botox, a specialized pharmaceutical product, by March 26, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business, for the supply of 100-unit vials of the drug BOTOX. The $3,691.84 order has a completion date of March 25, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds a broader indefinite delivery contract with DLA, valued up to $4,999,999, to provide a wide range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of Botox. The $22,151.04 delivery order has a completion date of March 6, 2024 and was awarded on February 13, 2024. DMS Pharmaceutical Group provides a range of pharmaceutical and medical supplies to government agencies, including the Department of Veterans Affairs and Department of Defense, through multiple prime and...
- This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,775.42 contract is for the delivery of 100-unit vials of Botox by June 11, 2025. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that specializes in supplying a wide range of medical products, including prescription drugs, biologics, and consumables, to federal healthcare facilities. The company holds...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 100-unit vials of Botox. The $23,074 contract has a completion date of February 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and delivery orders with DLA Troop Support Medical to supply a variety of pharmaceutical and medical items to military treatment facilities worldwide. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,306.64 firm fixed-price contract is for the delivery of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDG52Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of 100 unit vials of Botox at a firm fixed price of $46,148.00. The contract has no set-aside designation and the completion date is March 4, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Veterans Affairs and Department of Defense, through both prime and subcontracts. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract with DLA, valued at up to $4,999,999 through 2025, which enables the agency to order a broad selection of pharmaceutical items to meet the recurring medical supply needs of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.1k | 2/9/24 |